Abstract

I. 3.8 million died with tuberculosis infections at an accelerated rate since 2018 and the trend will continue to reach 4.6 million by 2030 (Table 1) (Figure 1).
II. Since 2018 the number of resistances has increased significantly, and the trend will continue until 2030, thus complicating treatment and increasing the costs from US dollars 8.2 billion in 2018 to dollars 32 billion in 2030 (Table 2) (Figure 2).
III. The costs associated with resistant tuberculosis management with direct and indirect costs have been increasing ever since 2023 (Table 2) (Figure 2).
IV. The Heal Africa research team has demonstrated on 155 patients that a solution to cure the non-resistant cases and resistant cases exists thus reducing the costs and eradicating tuberculosis worldwide (Table 3) (Figure 3).
V. The Heal Africa research team is seeking to expand the cohort study to 1000 patients to prove beyond doubt that this solution is unbiased.
VI. A projection chart to demonstrate the reduction of the death toll (from 4.05 million in 2024 to 0 in 2025) and the gains in terms of costs (from 18.8 US billion in 2024 to 1.8 US billion in 2025) by using our solution is given below (Table 3, Figure 3) & (Table 4, Figure 4).

Keywords

artemisia afra, resistant tuberculosis, non-resistant tuberculosis, costs